Sofinnova

Hemab raises $157M series C for rare bleeding disorder goals

The company will use the funding to build out its pipeline to advance its clinical candidates for Glanzmann thrombasthenia and von Willebrand disease.

Zoey Becker Oct 27, 2025 6:00am

Hiking gear with a forest in the background

Expedition resupplies for ph. 2 COPD voyage with $165M series A

Oct 9, 2025 9:50am

Gene therapy biotech secures $150M for eye disease candidates

Apr 2, 2025 7:30am

Europe Euro European biotech European startup fundraising

Sofinnova closes €165M European biotech acceleration fund

Mar 18, 2025 4:01am

Sofinnova's €1.2B to fuel up to 60 life sciences companies

Mar 4, 2025 4:56am

Why biotechs can benefit from the 'rational' IPO environment

Jan 24, 2025 10:30am